A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics

Patricia Smirnoff, Levava Roiz, Boaz Angelkovitch, Betty Schwartz, Oded Shoseyov

Cancer · 2006 · 66 citations · 41 references

DOIFull text

Open access

Abstract

The current results suggested that RNASET2 represents a new class of antitumorigenic and antiangiogenic drugs, and the findings of this study emphasize the advantage of using agents like RNASET2 in combined therapy.

References

41